A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa
Clinical trial NCT03836001 · COMPLETED
Trial details
- NCT number
- NCT03836001
- Sponsor
- Stanford University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-18
- Primary completion
- 2021-12-06
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.